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Microbially derived metabolites in the intestine regulate host immunity and impact disease pathophysiology
in various organs. Sun et al. (2015) suggest a direct effect of microbial metabolites on pancreatic endocrine
cells in regulating type 1 diabetes pathophysiology.Recent studies highlight the functional
interplay between the intestinal micro-
biota and host immune system impacting
disease pathophysiology beyond the
gut. Initial profiling studies of the intestinal
microbiome demonstrated major shifts in
taxa that occur in patients with diseases
such as multiple sclerosis, asthma, and
type I diabetes (T1D). These studies
paved the way for more functional ap-
proaches to determine how specific mi-
crobially produced products (i.e., metab-
olites) can impact immune responses in
mouse models and patients with these
diseases.
There are three logical mechanisms by
which intestinal microbial metabolites
can likely affect disease outcomes at
distant sites (Figure 1). First, somemetab-
olites can enter the systemic circulation in
high enough concentration to directly
alter cellular function at the target organ.
Second, metabolites in the systemic cir-
culation target immune cell development
and production at a secondary site (i.e.,
the bone marrow). These mobile immune
cells in turn interact with the target organ
and impact the disease. Lastly, intestinal
metabolites locally educate immune cells
within the intestine. These cells then
migrate to target organs and affect dis-
ease processes. These mechanisms are
not mutually exclusive and crosstalk with
the intestine is likely to further disease
progression. For example, enhanced in-
testinal permeability and increased risk
for food and microbial antigen exposure
in patients occurs in animal models of in-
flammatory diseases including T1D (Vaar-
ala et al., 2008). In addition, peptidogly-
cans found on gram-negative bacteria
can translocate into bone marrow neutro-
phils and systemically prime the innate
immune system (Clarke et al., 2010). A216 Immunity 43, August 18, 2015 ª2015 Elscurrent goal of work in this area is to
define mechanisms by which gut microbi-
al metabolites affect systemic disease
progression.
In this issue of Immunity, Sun et al.
(2015) demonstrate the role of systemic
microbial metabolites in shaping the
immune environment of the pancreas,
thereby conferring a degree of protection
against T1D. They propose that short
chain fatty acids (SCFA) produced by
the gut microbiota can directly signal
within pancreatic endocrine cells to
promote the synthesis of a key anti-in-
flammatory molecule. SCFAs including
acetate, propionate, and butyrate are
byproducts of microbial fermentation of
polysaccharides derived from host diet.
Recent studies have demonstrated their
immunoregulatory capabilities in several
inflammatory diseases including colitis,
asthma, and arthritis. Some key mecha-
nistic findings are that SCFAs drive ex-
tra-thymic differentiation of Foxp3+ regu-
latory T cells and regulate chemotaxis
of neutrophils (Maslowski et al., 2009).
Although the effects of SCFA on various
immune cell types have been well charac-
terized, their effects on extra-intestinal
cells during inflammatory diseases remain
largely unexplored.
Sun et al. (2015) focused on microbial
metabolites effects on islet endocrine
cells in inducing the secretion of cathe-
licidins related antimicrobial peptide
(CRAMP) during T1D. CRAMP (LL-37
in humans) was originally identified as
an antimicrobial peptide secreted by in-
testinal epithelial cells (differentiated colo-
nocytes) and immune cells. Similar to a-
and b-defensins, cathelicidins have highly
cationic regions, which are thought to
confer their targeting specificities for rela-
tively negatively charged bacterial mem-evier Inc.branes. In addition to their bactericidal ef-
fects, antimicrobial proteins can exert
effects on host cells in cellular regenera-
tion (i.e., regenerating islet-derived pro-
teins; Reg family), as well as immune
modulation. Previous studies (including
the authors’ previous work) described a
pro-inflammatory role of CRAMP in innate
and adaptive immune cells in several
autoimmune diseases including T1D
(Diana et al., 2013). Excessive production
of cathelicidin by neutrophils and its sub-
sequent formation of complexes with self-
nucleic acids was the proposed mecha-
nism. This cathelicidin/self-nucleic acid
complex targets plasmacytoid dendritic
cells via Toll-like receptors (TLRs) and
induce the type I IFN signature (Kahlen-
berg and Kaplan, 2013). However, the
neutrophil infiltration into the pancreas
in NOD mice was transient during the
early stage (Diana et al., 2013), and the
resulting IFN signature precedes T cell
activation and disease onset (Carrero
et al., 2013). Furthermore, clinical studies
have reported decreased serum concen-
trations of LL-37 in T1D patients, and
therefore, the role of CRAMP in the T1D
pathogenesis has been unclear.
Here, the authors described that
pancreatic islet cells in non-obese dia-
betic (NOD) female mice secreted less
CRAMP when compared to the male
counterpart or wild-type mice. In healthy
mice and humans, both glucagon-posi-
tive a-cells and insulin-positive b-cells
constitutively expressed CRAMP. The
amount of CRAMP secreted correlated
with disease susceptibility as female
NOD mice have higher disease incidence
compared to males, suggesting a poten-
tial protective role of pancreas-derived
CRAMP. Accordingly, exogenous admin-
istration of CRAMP in NOD female mice
Figure 1. Model of Intestinal Bacterial Metabolites Interacting with Host Immune System at
Distant Organs
Microbially derived metabolites in the intestine can regulate the host immune system and impact disease
pathophysiology in various organs distant from the intestine through three potential mechanisms: (1) me-
tabolites from the intestinal lumen (as represented by small circles) pass through the epithelium and enter
the systemic circulation to directly alter cellular function at the target organ; (2) metabolites in the systemic
circulation indirectly affect the target organ through altering immune cell development and function at a
secondary site (i.e., bone marrow); and (3) metabolites locally educate immune cells within the intestine
that then migrate to target organs. Arrows indicate migration of the immune cells from the secondary
site or intestine to the target organ. Sun et al. (2015) propose that luminal SCFA mediates direct effect
on pancreatic islets to secrete anti-inflammatory molecule to limit T1D progression.
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Previewsdampened the incidence of disease in two
separate models of diabetes. In vitro and
in vivo treatment with CRAMP skewed
macrophages and conventional dendritic
cells (cDC) to immunoregulatory types.
CRAMP-treated macrophages highly ex-
pressed the regulatory macrophage
markers CD206 and ALDH and secreted
anti-inflammatory cytokines such as
transforming growth factor-b (TGF-b).
CRAMP treatment similarly induced
immunoregulatory cDC. These regulatory
antigen-presenting cells in turn induced
both Foxp3+ Treg cells and interleukin-
10 (IL-10)-secreting Tr1 cells. These data
reveal a new function of CRAMP ininducing tolerigenic signatures to immune
cells similar to thymic stromal lympho-
poietin (TSLP), TGF-b, IL-10, and retinoic
acid.
The incidence of T1D in NOD mice is
well known to vary between the animal
housing facilities and can be modified
by exposure to microbial stimuli. The
absence of innate signaling through
pattern-recognition receptors in MyD88-
deficient NOD mice results in protection
against the disease in specific pathogen
free (SPF) facilities (Wen et al., 2008).
However, these mice develop disease
more rapidly in germ-free conditions.
Restoration of consortia of bacterial spe-Immunity 43cies in germ-free mice conferred protec-
tion in these mice, suggesting that spe-
cific microbes normally present in the
intestine can modify disease progression.
A number of studies have also implicated
hormonally driven microbiota composi-
tion as a determining factor for the gender
bias in T1D development. Re-derivation of
NOD mice as germ-free results in loss
of the gender bias, and re-colonization
of germ-free NOD mice with defined
bacterial species enriched in male mice
restored the male-associated protection
(Yurkovetskiy et al., 2013). In a separate
study, fecal transfer of male-associated
microbiota to immature females also
conferred protection in a hormone-
dependent manner (Markle et al., 2013).
Sun et al. (2015) found that NOD female
mice exhibited lower levels of fecal SCFA
compared to the male counterpart and
wild-type mice. Despite the relatively
small differences in luminal butyrate, the
authors hypothesized that diminished
concentrations of SCFA was responsible
for the decreased production of CRAMP
by islet cells in NOD female mice, ulti-
mately resulting in the gender bias. Sys-
temic administration of butyrate induced
a significant increase of pancreatic
CRAMP expression and dampened the
disease incidence in female NOD mice.
In contrast, removal of SCFA-producing
bacteria by antibiotics treatment in males
correlated with decreased production of
CRAMP and increased disease inci-
dence. Importantly, CRAMP expression
was restored in female NOD mice by
receiving fecal transfer from the male
mice, further supporting the role of intesti-
nal microbiota. As high abundance of
butyrate-producing bacteria remained
preserved in female NOD mice after
fecal transfer, the authors concluded
that the protective effect was hormone-
dependent, as well as SCFA-dependent.
Although the previous studies on
gender bias did not specifically examine
SCFA-producing bacteria, both studies
described higher abundance of SCFA-
producing Firmicutes family including
Roseburia and Veillonellaceae in male
versus female NOD mice (Yurkovetskiy
et al., 2013; Markle et al., 2013), poten-
tially supporting this current study.
Incidence for T1D has dramatically
increased in industrialized countries since
the 1950s, suggesting that changes in the
environment including diet and microbial, August 18, 2015 ª2015 Elsevier Inc. 217
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Previewsexposure influence disease pathogen-
esis. Studies using high-fat, low-fiber
Western diet have demonstratedmajor al-
terations in the microbial composition in
the gut, characterized by decrease in the
abundance of butyrate-producing spe-
cies. Therefore, the current study poten-
tially highlights the mechanistic link be-
tween increase in T1D incidence and
changes in diet in Westernized societies.
There is a rising interest in the functional
impact of microbial metabolites on host
physiology. Major challenges in the field
include determining relevant sites of sam-
pling, better sensitivity for detection, and
accurate identification of the metabolites.
To date, fecal metabolites have been
most commonly examined, but there is
an increasing awareness for the need
to examine metabolites from tissue-asso-
ciated microbes. Although mass spec-
trometry and NMR techniques have
been useful in detecting and identifying
metabolites, a substantial number of
candidate metabolites have not been an-
notated. Also, current genetic modifica-
tion techniques and robust culture
methods exist only for a fraction of the
intestinal bacteria that have been map-
ped, and the standard experimental ap-
proaches to study the function of micro-
biota involve removal and recolonization218 Immunity 43, August 18, 2015 ª2015 Elsof those culturable bacteria. Even with a
refined experimental system, it is chal-
lenging to distinguish the source of me-
tabolites as host cells andmicrobes utilize
many common metabolic pathways. Sun
et al. (2015) propose that butyrate directly
signals on b-cells as they express G pro-
tein-coupled receptors (GPR) 41 and 43,
the two receptors for SCFA. Although
addition of butyrate to islet culture
potently induced CRAMP expression
in vitro, butyrate was not detectable in
the islets of healthy mice at baseline
in vivo. Although the luminal concentra-
tions of SCFA are50mM, systemic con-
centrations are much lower (1–10 mm).
Furthermore, systemic injection of su-
pra-physiologic doses of butyrate might
not accurately represent in vivo condi-
tions. Their data suggest that the immu-
noregulatory effect of butyrate in T1D is
CRAMP-dependent, though one cannot
rule out the role of CRAMP-independent
differentiation of Tregs and regulatory
macrophages directly mediated by buty-
rate. Therefore, future experiments are
required to prove that such a direct effect
occur in vivo and whether homeostatic
levels of systemic SCFA confer protection
against the disease onset in healthy mice.
Despite these caveats, this study is an
important step forward.evier Inc.REFERENCES
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The molecular mechanisms important to generate innate natural killer cell ‘‘memory’’ are poorly understood.
In this issue of Immunity, O’Sullivan et al. (2015) demonstrate that mitophagy plays a critical role in natural
killer cell memory formation following viral infection.The mammalian immune system is classi-
cally divided into rapid, non-specific
innate immunity and slower-developing,
antigen-specific adaptive immunity that
exhibits immunologic memory. Memory
in immune lingo conventionally denotesa more robust, rapid secondary response
to a previously encountered ‘‘priming’’ in-
fectious challenge. Natural killer (NK) cells
are innate lymphoid cells important for
host defense against viral infection and
malignancy, which is primarily achievedvia direct target cell killing and the pro-
duction of effector cytokines (e.g., IFN-g)
and chemokines. Unlike adaptive T and
B lymphocytes that recombine the DNA
of antigen receptor genes to express
a dominant, antigen-specific activating
